- Report
- February 2021
- 15 Pages
Global
€1906EUR$2,000USD£1,635GBP
- Report
- February 2020
- 1137 Pages
Global
€19062EUR$20,000USD£16,352GBP
- Report
- May 2021
- 112 Pages
Global
From €3200EUR$3,597USD£2,841GBP
- Report
- January 2024
- 94 Pages
Global
From €3500EUR$3,934USD£3,107GBP
- Report
- August 2023
- 97 Pages
Global
From €3500EUR$3,934USD£3,107GBP
- Report
- August 2021
- 102 Pages
Global
From €3200EUR$3,597USD£2,841GBP
- Report
- October 2023
- 146 Pages
Global
From €3362EUR$3,528USD£2,884GBP
€3955EUR$4,150USD£3,393GBP
- Report
- March 2024
- 132 Pages
Global
From €905EUR$950USD£777GBP
- Book
- September 2023
- 448 Pages
Label Free Detection (LFD) is a technology used in biotechnology to detect and quantify biomolecules without the need for labeling. It is used in a variety of applications, such as drug discovery, diagnostics, and proteomics. LFD is based on the principle of measuring the intrinsic optical properties of a molecule, such as its refractive index, absorbance, or fluorescence. This allows for the detection of molecules without the need for labeling, which can be expensive and time-consuming.
LFD is used in a variety of biotechnology applications, such as drug discovery, diagnostics, and proteomics. In drug discovery, LFD can be used to identify and quantify drug targets, as well as to monitor the effects of drug compounds on cells. In diagnostics, LFD can be used to detect and quantify biomarkers, such as proteins, nucleic acids, and metabolites. In proteomics, LFD can be used to identify and quantify proteins in complex biological samples.
Some companies in the Label Free Detection market include Bio-Rad, Agilent Technologies, PerkinElmer, Thermo Fisher Scientific, and Bruker. Show Less Read more